Lack of association between VEGF -2578C/A polymorphism and risk of colorectal cancer in an Iranian population
Gastroenterology and Hepatology from Bed to Bench,
,
9 December 2020
,
Page S47-S52
https://doi.org/10.22037/ghfbb.v13i1.2203
Abstract
Aim: Here, we evaluated the VEGF gene -2578C/A polymorphism as a potential susceptibility factor in colorectal cancer (CRC) occurrence amongst Iranian CRC patients.
Background: Vascular endothelial growth factor (VEGF) is a key regulatory factor in angiogenesis which plays essential roles in the development of malignancy in colorectal cancer (CRC), as the third most prevalent cancer worldwide.
Methods: VEGF -2578C/A polymorphism was evaluated in 200 CRC patients and 200 healthy control subjects via restriction fragment length polymorphism analysis.
Results: The frequencies of CC, AC and AA genotypes among CRC patients were 22.5%, 51% and 26.5%, respectively, with their respective genotype frequencies at 16%, 54% and 30% in control cohorts (P=0.247). The A allele frequency among the case group was 52% and for control group, it was 57%. C allele frequency in case and control groups was 48% and 43%, respectively (p=0.156). No significant association was observed (p=0.990) between this polymorphism and CRC stage.
Conclusion: Our findings provide limited support for the hypothesis that the -2578C/A VEGF are associated with increased risk of colorectal cancer in Iranian colorectal cancer patients and suggest instead that meta data studies, which have previously relied upon populations definitions such as ‘Asian’, should more specifically take into account country of origin when associating prognostic value to a given genotype.
Keywords: Colorectal cancer, Angiogenesis, VEGF, Single nucleotide polymorphism, Vascular endothelial growth factor.
(Please cite as: Savabkar S, Zali N, Hadizadeh M, Tavangarroosta SH, Young CH, Shojaeian F, et al. Lack of association between VEGF -2578C/A polymorphism and risk of colorectal cancer in an Iranian population Gastroenterol Hepatol Bed Bench 2020;13(Suppl.1):S47-S52).
- Colorectal cancer, Angiogenesis, VEGF, Single Nucleotide Polymorphism, Vascular Endothelial Growth Factor
References
Deschoolmeester V, Baay M, Specenier P, Lardon F, Vermorken JB. A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy. Oncologist 2010;15:699-731.
Qasim Alhilfia HS, Mohsin Almohammadawi KO, Abduljalil Alsaad RK, Ameen NA, Abbood Aliedani BK, Imran Aldubaisi HJ, et al. Colorectal cancer epidemiology and clinical study in Misan. J Coloproctol 2019;39:159-62.
Haddad FG, Eid R, Kourie HR, Barouky E, Ghosn M. Prognostic and predictive biomarkers in nonmetastatic colorectal cancers. Future Oncol 2018;14:21.
Mo Bae J, Rhee YY, Kim KJ, Wen X, Seok Song Y, Cho NY, et al. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype–high colorectal cancers? Human Pathol 2016;47:85-94.
Chayeb V, Mahjoub S, Zitouni H, Jrah-Harzallah H, Zouari K. Contribution of microRNA-149, microRNA-146a, and microRNA-196a2 SNPs in colorectal cancer risk and clinicopathological features in Tunisia. Gene 2018;666:100-7.
Farnood A, Naderi N, Moghaddam SJ, Noorinayer B, Firouzi F, Aghazadeh R, et al. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. Int J Colorectal Dis 2007;22:999-1003.
Crockett SD, Nagtegaal I. Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia. Gastroenterology 2019;157:949-66.
Yamazaki K, Taniguchi H, Yoshino T, Akagi K, Ishida H, Ebi H, et al. Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition. Cancer Sci 2018;109:2074-9.
Du W, Ma XL, Zhao C, Liu T, Du YL, Kong WQ, et al. Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility. Asian Pac J Cancer Prev 2014;15:1047-55.
Liu Y, Lin XF, Lin CJ, Jin SS, Wu JM. Transforming growth factor beta-1 C-509T polymorphism and cancer risk: a meta-analysis of 55 case-control studies. Asian Pac J Cancer Prev 2012;13:4683-8.
Yue AM, Xie ZB, Zhao HF, Guo SP, Shen YH, Wang HP. Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population. Asian Pac J Cancer Prev 2013;14:3085-91.
Goudarzi M, Goudarzi H, Alebouyeh M, Azimi Rad M, Shayegan Mehr FS, Zali MR, et al. Antimicrobial susceptibility of clostridium difficile clinical isolates in iran. Iran Red Crescent Med J 2013;15:704-11.
Zhang Y, Zhang D, Zhao L, Lili Sun L, Dong Q, Cheng L, et al. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis. Curr Probl Cancer 2018;42:582-92.
Saeed HM, Alanazi MS, Parine NR, Shaik J, Semlali A, Alharbi O, et al. Matrix metalloproteinase-2 (-1306 c > t) promoter polymorphism and risk of colorectal cancer in the Saudi population. Asian Pac J Cancer Prev 2013;14:6025-30.
Canavese M, Ngo DT, Maddern GJ, Hardingham JE, Price TJ, Hauben E. Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer. Int J Cancer 2017;140:2183-91.
Nishida N,Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc Health Risk Manag 2016;2:213-9.
Ruhrberg C. Endogenous inhibitors of angiogenesis. J Cell Sci 2001;114:3215-6.
Takahashi S. Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumour therapy. Biol Pharm Bull 2011;34:1785-8.
Roy H, Bhardwaj S, Ylä-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006;580:2879-87.
Pentheroudakis G, Leonidas Mavroeidis L, Papadopoulou K, Koliou GA, Bamia C, Chatzopoulos K, et al. Angiogenic and anti-angiogenic VEGFA splice variants in colorectal cancer: A prospective retrospective cohort study in patients treated with irinotecan-based chemotherapy and bevacizumab. Clin Colorectal cancer 2019;18:e370-84.
Schomber T, Zumsteg A, Strittmatter K, Crnic I, Antoniadis H, Littlewood-Evans A, et al. Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumour angiogenesis and tumour lymphangiogenesis. Mol Cancer Ther 2009;8:55-63.
Tonini T, Rossi F, Claudio PP. Molecular basis of angiogenesis and cancer. Oncogene 2003;22:6549-56.
Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Siviridisc E. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 2004;46:293-8.
Kim YH, Kim MA, Park IA, Park WY, Kim JW, Kim SC, et al. VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival. Gynecol Oncol 2010;119:232-6.
Supic G, Jovic N, Zeljic K, Kozomara R, Magic Z. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. Oral Oncol 2012;48:1171-7.
Jannuzzi AT, Özhan G, Yanar HT. Alpertunga B VEGF Gene Polymorphisms and Susceptibility to Colorectal Cancer. Genet Test Mol Biomarkers 2015;19:133-7.
Spielmann M, Lupiáñez DG, Mundlos S. Structural variation in the 3D genome. Nat Rev Genet 2018;19:453-67.
Vannitamby A, Hendry S, Makadia T, Danks J, Slavin J, Irving L, et al. A Novel Approach to Detect Programed Death Ligand 1 (PD-L1) Status and Multiple Tumor Mutations Using a Single Non–Small-Cell Lung Cancer (NSCLC) Bronchoscopy Specimen. J Mol Diagn 2019;21:186-97.
Joshi MS, Berger PJ, Kaye DM, Pearson JT, Bauer JA, Ritchie RH. Functional relevance of genetic variations of endothelial nitric oxide synthase and vascular endothelial growth factor in diabetic coronary microvessel dysfunction. Clin Exp Pharmacol Physiol 2013;40:253-61.
Cao C, Ying T, Fang JJ, Sun S F, Lv D, Zhong-Bo Chen ZB, et al. Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects. Med Oncol 2011;28:1169-75.
Clar H, Krippl P, Renner W, Langsenlehner T, Clar V, Windhager R , et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2009;113:197-8.
Wang L, Ji S, Cheng Z. Vascular endothelial growth factor -2578C/A polymorphism and colorectal cancer risk: A meta-analysis. J Res Med Sci 2015;20:811-7.
Al-Balawi IA, Mir R, Abu-Duhier FM. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C >A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study. Asian Pac J Cancer Prev 2018;19:1135-43.
Yang PW, Hsieh MS, Huang YC, Hsieh CY, Chiang TH, Lee JM. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma. PLoS One 2014;9:e100326.
Liu W, Dong Z, Hu R, Wang C. Association of Vascular Endothelial Growth Factor (VEGF) Gene Polymorphisms with Gastric Cancer and Its Development, Prognosis, and Survival. Technol Cancer Res Treat 2018;17: 1533034617753810.
Miller S, Dykes D, Polesky HA. simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
Álvarez-Aznar A, Muhl L, Gaengel K. VEGF Receptor Tyrosine Kinases: Key Regulators of Vascular Function. Curr Top Dev Biol 2017;123:433-82.
Hofmann G, Langsenlehner U, Renner W, Langsenlehner T, Yazdani-Biuki B, Clar H, et al. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clinical Oncol 2008;134:591-5.
Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000;12:1232-5.
Berardi R, Torniai M, Partelli S, Rubini C, Pagliaretta S, Savini A, et al. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms. PLoS One 2018;13:e0197035.
Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245-9.
Uthoff SM, Duchrow M, Schmidt MH, Broll R, Bruch HP, Strik MW, et al. VEGF isoforms and mutations in human colorectal cancer. Int J Cancer 2002;101:32-6.
Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1635-9.
Li X. The association between MCP-1, VEGF polymorphisms and their serum levels in patients with diabetic foot ulcer. Medicine 2018;97:e10959.
Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005;11:3647-53.
Bhanoori M, Arvind Babu K, Pavankumar Reddy NG, Lakshmi Rao K, Zondervan K, Deenadayal M, et al. The vascular endothelial growth factor (VEGF)+ 405G > C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod 2005;20:1844-9.
Góralczyk B, Smolarz B, Romanowicz H, Szyłło K. Single nucleotide polymorphisms of VEGF gene in endometriosis. Pol Merkur Lekarski 2012;32:151-3.
Vidaurreta M, Sánchez-Muñoz R, Veganzones S, Rafael S, Gutiérrez M. Vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer. Rev Esp Enferm Dig 2010;102:20.
Masoodi M, Zali MR, Ehsani-Ardakani MJ, Mohammad-Alizadeh AH, Aiassofi K, Aghazadeh R, et al. Abdominal pain due to lead-contaminated opium: a new source of inorganic lead poisoning in Iran. Arch Iran Med. 2006;9:72-5.
Nazemalhosseini Mojarad E, Kuppen PJ, Aghdaei HA, Zali MR. The CpG island methylator phenotype (CIMP) in colorectal cancer. Gastroenterol Hepatol Bed Bench 2013;6:120-8.
Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, Christoni Z, Nikiteas N, et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 2009;48:563-9.
- Abstract Viewed: 0 times
- PDF Downloaded: 0 times
